We are not saying GLP-1 drugs prevent cancer
Mice were administered a single topical drop (2.5 L) of NAC (18.35 mg/mL) or NACET (21.5 mg/mL) gel-forming drops, or gel-forming vehicle alone bilaterally daily starting from when their eyes opened (P13-15) through P65
Regulations: Most countries have not approved it as a drug and it is for research purposes
[19] Patients should maintain adequate hydration during the initial treatment period, as gastrointestinal side effects can increase dehydration risk, which may lead to acute kidney injury in severe cases
Key areas requiring investigation include bioavailability enhancement strategies, therapeutic window identification, and patient stratification based on genetic and environmental factors
Common reasons for switching include weight changes, sleep disruption, sexual dysfunction, and emotional blunting